跳至主要内容
临床试验/NCT03113786
NCT03113786已完成4 期

Efficacy of Amniotic Tissue (CLARIX 100 & CLARIX CORD 1K) in Pain Reduction and Improvement of Function in Low Back & Leg Pain in Discectomy Patients

Amniox Medical, Inc.1 个研究点 分布在 1 个国家目标入组 32 人开始时间: 2011年11月2日最近更新:
适应症
干预措施

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
32
试验地点
1
主要终点
Difference in low back & leg pain

研究概览

简要总结

The purpose of the study is to evaluate the efficacy of CLARIX™ 100 and CLARIX™ CORD 1K as a tissue barrier when used as an annular patch in discectomy patients with low back & leg pain when compared to traditional discectomy patient outcomes. This will be a 120 patient, prospective randomized study model over a 5 year post-operative period.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Patients between 18 and 90 years of age
  • •Patient is able to understand the aims and objectives of the trial and the trial procedures
  • •Patient is willing to give written informed consent to the trial
  • •Patient is able to follow up with regularly scheduled visits with and phone calls from Dr. Anderson and his research staff
  • •Diagnosed with lumbar protruding disc
  • •Suffer from radiating leg pain and low back pain that has failed a minimum of 6 months of conservative (non-operative) treatment options

排除标准

  • •Participation in clinical trial involving therapy for back pain within 30 days of screening
  • •Prior back surgery at the same level
  • •Inability to walk independently (adaptive devices such as walkers or canes are allowed)
  • •Relation (whether direct or indirect) to, student of, employee of, colleague of, indebted to the primary investigator, host institution or sponsoring company
  • •Receipt of corticosteroids, immunosuppressive agents, radiation therapy or chemotherapy within 1 month prior to visit
  • •Pregnancy or planning to become pregnant during study period
  • •Body Mass Index >50
  • •Patients with chronic diseases such as Crohn's disease, severe renal failure (serum creatinine 2.5 mg/dL or subject on hemodialysis), severe hepatic insufficiency: known cirrhosis, any degree of ascites, serum transaminases more than 3 times the upper limit of normal, life expectancy of less than one year, uncompensated or uncontrolled right sided heart failure with associated edema
  • •Severe anemia, hemoglobin <8.5 mg/dL
  • •Active, local or systemic malignancy such as lung cancer or leukemia
  • •Severe hypertension (systolic blood pressure greater than or equal to 200 mmHg or diastolic blood pressure greater than or equal to 100 mmHg)
  • •Severe hypoxia, with chronic oxygen or ventilation therapy
  • •History of collagen vascular disease or sickle cell anemia
  • •Active rheumatoid arthritis
  • •Systemic antibiotic therapy for any indication within 10 days of screening

研究组 & 干预措施

Standard of Care

No Intervention

Subjects randomized to standard of care will undergo a traditional lumbar discectomy procedure without any additional interventions

CLARIX™100

Active Comparator

Subjects randomized to the CLARIX™100 arm will undergo a traditional lumbar discectomy, after which CLARIX™100 will be applied to the affected site. The tissue will be applied to the annulus at the defect site as a patch just prior to wound closure.

干预措施: CLARIX™100 (Other)

CLARIX CORD 1K

Active Comparator

Subjects randomized to the CLARIX CORD 1K arm will undergo a traditional lumbar discectomy, after which CLARIX CORD 1K will be applied to the affected site. The tissue will be applied to the annulus at the defect site as a patch just prior to wound closure.

干预措施: CLARIX CORD 1K (Other)

结局指标

主要结局

Difference in low back & leg pain

时间窗: 5 years

To determine at various time points up to 5 years what, if any, difference there is between the three groups of 40 patients by using the Oswestry Disability Index scales for both back \& leg pain

次要结局

未报告次要终点

研究者

发起方
Amniox Medical, Inc.
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验